Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For May 11 (JPM, JWN, NVDA, GKNT, ARNA, WWWW)

Gainers:

NVIDIA Corp. (NVDA: Quote) is up 7 percent to $13.34. The company's first quarter profit plunged from the year-ago quarter. Revenue declined from the prior year period, but was above Wall Street view. Meanwhile, the company guided second quarter revenue above consensus.

Arena Pharmaceuticals, Inc. (ARNA: Quote) is jumping 92 percent to $7.05. The company announced that the FDA Endocrinologic and Metabolic Drugs Advisory Committee has recommended the approval of its investigational drug candidate lorcaserin intended for weight management.

Decliners:

JPMorgan Chase & Co. (JPM: Quote) is down 8 percent to $37.46. The company disclosed that since March 31, 2012, its Chief Investment Office has had hefty mark-to-market losses in its synthetic credit portfolio that has proved to be more riskier than expected. The company currently estimates its Corporate business, within the Corporate/Private Equity segment, to incur a net loss in its second quarter of about $800 million, which excludes Private Equity results and litigation expense.

Nordstrom, Inc. (JWN: Quote) is declining 4 percent to $51.55. The company's first quarter profit increased from the previous year period, but missed Wall Street view. Net sales improved 13.7 percent, while same-store sales increased 8.5 percent. Meanwhile, the company expects fiscal 2012 earnings per share below analysts' estimate.

Web.com Group, Inc. (WWWW: Quote) is falling more than 2 percent to $15.16. The company announced the pricing of public offering of 8 million shares of its common stock by certain selling stockholders at $15.25 per share.

Trading halt:

Trading in shares of Geeknet, Inc. (GKNT: Quote) was halted. The company announced its plan to explore strategic alternatives with respect to its online media business, including the SourceForge, Slashdot and Freecode websites.

Register
To receive FREE breaking news email alerts for JPMorgan Chase & Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.